Metrovacesa S.A [MVC] vs Vidrala S.A [VID] Detailed Stock Comparison

Metrovacesa S.A.

BME
Loading...

Vidrala S.A.

BME
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Metrovacesa S.A. wins in 7 metrics, Vidrala S.A. wins in 12 metrics, with 0 ties. Vidrala S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Metrovacesa S.A. Vidrala S.A. Better
P/E Ratio (TTM) 32.05 13.14 Vidrala S.A.
Price-to-Book Ratio 1.27 1.95 Metrovacesa S.A.
Debt-to-Equity Ratio 30.73 18.61 Vidrala S.A.
PEG Ratio 26.95 11.05 Vidrala S.A.
EV/EBITDA 15.98 7.02 Vidrala S.A.
Profit Margin (TTM) 8.03% 13.85% Vidrala S.A.
Operating Margin (TTM) 24.31% 19.00% Metrovacesa S.A.
EBITDA Margin (TTM) 24.31% 19.00% Metrovacesa S.A.
Return on Equity 3.78% 15.38% Vidrala S.A.
Return on Assets (TTM) 3.38% 7.87% Vidrala S.A.
Free Cash Flow (TTM) $216.93M $191.78M Metrovacesa S.A.
Dividend Yield 21.46% 3.21% Metrovacesa S.A.
1-Year Return 10.38% -19.21% Metrovacesa S.A.
Price-to-Sales Ratio (TTM) 2.54 1.80 Vidrala S.A.
Enterprise Value $2.04B $2.90B Vidrala S.A.
EV/Revenue Ratio 2.88 1.92 Vidrala S.A.
Gross Profit Margin (TTM) -11.75% N/A N/A
Revenue per Share (TTM) $5 $43 Vidrala S.A.
Earnings per Share (Diluted) $0.37 $5.95 Vidrala S.A.
Beta (Stock Volatility) 0.70 0.82 Metrovacesa S.A.

Metrovacesa S.A. vs Vidrala S.A. Stock Performance Analysis

Loading Price Chart...

MVC
VID

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Metrovacesa S.A.-1.35%-6.40%6.85%21.62%10.90%25.00%
Vidrala S.A.-0.26%-4.05%3.85%-14.07%-8.05%-13.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Metrovacesa S.A.10.38%54.35%53.34%-24.52%-24.52%-24.52%
Vidrala S.A.-19.21%-13.75%-3.29%102.91%383.01%387.23%

Performance & Financial Health Analysis: Metrovacesa S.A. vs Vidrala S.A.

MetricMVCVID
Market Information
Market Cap i€1.80B€2.73B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i138,11641,164
90 Day Avg. Volume i143,98952,877
Last Close€11.70€78.20
52 Week Range€8.82 - €13.50€70.40 - €100.60
% from 52W High-13.33%-22.27%
All-Time High€16.69 (Feb 05, 2018)€113.60 (Jun 03, 2024)
% from All-Time High-29.90%-31.16%
Growth Metrics
Quarterly Revenue Growth0.36%N/A
Quarterly Earnings Growth5.00%N/A
Financial Health
Profit Margin (TTM) i0.08%0.14%
Operating Margin (TTM) i0.24%0.19%
Return on Equity (TTM) i0.04%0.15%
Debt to Equity (MRQ) i30.7318.61
Cash & Liquidity
Book Value per Share (MRQ)€9.33€40.16
Cash per Share (MRQ)€1.28€3.11
Operating Cash Flow (TTM) i€217.11M€380.29M
Levered Free Cash Flow (TTM) i€208.51M€151.72M
Dividends
Last 12-Month Dividend Yield i21.46%3.21%
Last 12-Month Dividend i€1.91€2.78

Valuation & Enterprise Metrics Analysis: Metrovacesa S.A. vs Vidrala S.A.

MetricMVC (Apr 24, 2026)VID (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i32.0513.14
Forward P/E i26.9511.05
PEG Ratio i26.9511.05
Price to Sales (TTM) i2.541.80
Price to Book (MRQ) i1.271.95
Market Capitalization
Market Capitalization i€1.80B€2.73B
Enterprise Value i€2.04B€2.90B
Enterprise Value Metrics
Enterprise to Revenue i2.881.92
Enterprise to EBITDA i15.987.02
Risk & Other Metrics
Beta i0.700.82
Book Value per Share (MRQ) i€9.33€40.16

Financial Statements Comparison: Metrovacesa S.A. vs Vidrala S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMVC (2025)VID (2025)
Revenue/Sales i708.46M1.47B
Cost of Goods Sold i528.83M584.15M
COGS % of Revenue i74.6%39.8%
Gross Profit i179.63M883.13M
Gross Margin i25.4%60.2%
Research & Development iN/AN/A
Operating Income (EBIT) i80.92M294.43M
Operating Margin i11.4%20.1%
EBITDA i97.19M442.97M
EBITDA Margin i13.7%30.2%
Pre-Tax Income i72.54M276.66M
Pre-Tax Income % of Revenue i10.2%18.9%
Income Tax i15.68M67.32M
Income Tax % of Revenue i2.2%4.6%
Net Income (Profit) i56.86M209.34M
Profit Margin i8.0%14.3%

Balance Sheet & Liquidity Metrics

MetricMVC (2025)VID (2025)
Cash & Equivalents i130.28M108.35M
Total Current Assets i1.87B712.56M
Total Current Assets % of Revenue i264.6%48.6%
Total Current Liabilities i521.45M452.14M
Total Current Liabilities % of Revenue i73.6%30.8%
Long-Term Debt i253.71M92.61M
Long-Term Debt % of Revenue i35.8%6.3%
Total Shareholders Equity i1.41B1.41B
Retained Earnings i-205.01M1.50B
Retained Earnings % of Revenue i-28.9%102.2%
Property, Plant & Equipment iN/A1.14B

Cash Flow Statement Comparison

MetricMVC (2025)VID (2025)
Operating Cash Flow i216.52M300.59M
Operating Cash Flow % of Revenue i30.6%20.5%
Capital Expenditures i-179,000-188.50M
Free Cash Flow i216.93M191.78M
FCF Margin i30.6%13.1%
Debt Repayment i-355.67MN/A
Common Stock Repurchase i-260,000-1.29M

Short Interest & Institutional Ownership Analysis

MetricMVCVID
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i151.55M35.18M
Float Shares i6.93M21.81M
% Held by Insiders i92.47%35.75%
% Held by Institutions i2.17%15.21%
% Held by Public i5.36%49.04%

Dividend Analysis & Yield Comparison: Metrovacesa S.A. vs Vidrala S.A.

MetricMVCVID
Last 12-Month Dividend i€1.91€2.78
Last 12-Month Dividend Yield i21.46%3.21%
3-Year Avg Annual Dividend i€0.98€2.90
3-Year Avg Dividend Yield i5.58%1.16%
3-Year Total Dividends i€2.93€8.69
Ex-Dividend DateDec 19, 2025Feb 11, 2026